SK279200B6 - Biomasa na výrobu vírus/vírus antigénu jej použiti - Google Patents
Biomasa na výrobu vírus/vírus antigénu jej použiti Download PDFInfo
- Publication number
- SK279200B6 SK279200B6 SK12-91A SK1291A SK279200B6 SK 279200 B6 SK279200 B6 SK 279200B6 SK 1291 A SK1291 A SK 1291A SK 279200 B6 SK279200 B6 SK 279200B6
- Authority
- SK
- Slovakia
- Prior art keywords
- virus
- production
- viruses
- antigen
- biomass
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 80
- 239000000427 antigen Substances 0.000 title claims abstract description 47
- 239000002028 Biomass Substances 0.000 title claims abstract description 33
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims description 13
- 102000036639 antigens Human genes 0.000 title abstract description 44
- 108091007433 antigens Proteins 0.000 title abstract description 44
- 239000001963 growth medium Substances 0.000 claims abstract description 18
- 230000002503 metabolic effect Effects 0.000 claims abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 17
- 239000001301 oxygen Substances 0.000 claims description 17
- 229910052760 oxygen Inorganic materials 0.000 claims description 17
- 241001465754 Metazoa Species 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 3
- 238000004220 aggregation Methods 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000000725 suspension Substances 0.000 abstract description 10
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 55
- 210000002308 embryonic cell Anatomy 0.000 description 6
- 238000004062 sedimentation Methods 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 241000271566 Aves Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 241000710771 Tick-borne encephalitis virus Species 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000009331 sowing Methods 0.000 description 3
- 241000700663 Avipoxvirus Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 101710186708 Agglutinin Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000011475 meningoencephalitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT18/90A AT393277B (de) | 1990-01-04 | 1990-01-04 | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
SK279200B6 true SK279200B6 (sk) | 1998-07-08 |
Family
ID=3479351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK12-91A SK279200B6 (sk) | 1990-01-04 | 1991-01-04 | Biomasa na výrobu vírus/vírus antigénu jej použiti |
Country Status (17)
Country | Link |
---|---|
US (2) | US5391491A (xx) |
EP (1) | EP0509008B1 (xx) |
JP (1) | JP2633392B2 (xx) |
AT (2) | AT393277B (xx) |
CA (1) | CA2073168C (xx) |
CZ (1) | CZ279725B6 (xx) |
DE (1) | DE59103696D1 (xx) |
DK (1) | DK0509008T3 (xx) |
ES (1) | ES2067921T3 (xx) |
FI (1) | FI106241B (xx) |
HR (1) | HRP921353A2 (xx) |
HU (1) | HU212597B (xx) |
NO (1) | NO310472B1 (xx) |
RU (1) | RU2099419C1 (xx) |
SK (1) | SK279200B6 (xx) |
WO (1) | WO1991009937A1 (xx) |
YU (1) | YU391A (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5719051A (en) * | 1989-12-22 | 1998-02-17 | Immuno Aktiengesellschaft | Perfusion system and a method for the large scale production of virus or virus antigen |
AT393277B (de) * | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
EP2290053A1 (en) | 1994-11-10 | 2011-03-02 | Baxter Healthcare S.A. | Method for producing Influenza virus in protein-free cell culture medium |
US5753489A (en) * | 1994-11-10 | 1998-05-19 | Immuno Ag | Method for producing viruses and vaccines in serum-free culture |
US5698433A (en) * | 1994-11-10 | 1997-12-16 | Immuno Ag | Method for producing influenza virus and vaccine |
US5756341A (en) * | 1994-11-10 | 1998-05-26 | Immuno Ag | Method for controlling the infectivity of viruses |
DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
BR9804283B1 (pt) * | 1998-03-18 | 2010-11-30 | processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura. | |
US7445924B2 (en) * | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
DE10144906B4 (de) | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
US20040023358A1 (en) * | 2001-12-21 | 2004-02-05 | Wyeth | Avian embryo particulate biomass for the production of virus antigens |
NZ538575A (en) * | 2002-09-05 | 2007-03-30 | Bavarian Nordic As | Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors |
US7998488B2 (en) | 2008-11-14 | 2011-08-16 | Baxter International Inc. | Vaccine formulations and uses thereof |
JP2013538577A (ja) | 2010-09-23 | 2013-10-17 | バクスター・インターナショナル・インコーポレイテッド | 組み換えウイルスベクターおよび黄熱病ウイルスに対する免疫反応を惹起するための方法 |
CN103458922B (zh) | 2011-01-31 | 2017-10-03 | 纳米医疗公司 | 诱导对甲型流感病毒的异源亚型免疫反应的重组病毒载体和方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4059485A (en) * | 1976-11-03 | 1977-11-22 | Monsanto Company | Adaptation of cell lines to suspension culture |
US4195130A (en) * | 1978-04-20 | 1980-03-25 | Cornell Research Foundation, Inc. | Propagation of feline infectious peritonitis virus in tissue cultures |
AT358167B (de) * | 1978-12-22 | 1980-08-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen |
US4335215A (en) * | 1980-08-27 | 1982-06-15 | Monsanto Company | Method of growing anchorage-dependent cells |
AT393277B (de) * | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
US5114855A (en) * | 1990-04-19 | 1992-05-19 | Regents Of The University Of Minnesota | Method for aggregating cells with small microspheres |
-
1990
- 1990-01-04 AT AT18/90A patent/AT393277B/de not_active IP Right Cessation
-
1991
- 1991-01-03 EP EP19910901647 patent/EP0509008B1/de not_active Expired - Lifetime
- 1991-01-03 RU SU925052917A patent/RU2099419C1/ru not_active IP Right Cessation
- 1991-01-03 DK DK91901647T patent/DK0509008T3/da active
- 1991-01-03 DE DE59103696T patent/DE59103696D1/de not_active Expired - Fee Related
- 1991-01-03 AT AT91901647T patent/ATE114713T1/de not_active IP Right Cessation
- 1991-01-03 YU YU391A patent/YU391A/sh unknown
- 1991-01-03 US US07/854,630 patent/US5391491A/en not_active Expired - Lifetime
- 1991-01-03 JP JP50199791A patent/JP2633392B2/ja not_active Expired - Fee Related
- 1991-01-03 WO PCT/AT1991/000003 patent/WO1991009937A1/de active IP Right Grant
- 1991-01-03 CA CA 2073168 patent/CA2073168C/en not_active Expired - Lifetime
- 1991-01-03 ES ES91901647T patent/ES2067921T3/es not_active Expired - Lifetime
- 1991-01-03 HU HU9202127A patent/HU212597B/hu unknown
- 1991-01-04 CZ CS9112A patent/CZ279725B6/cs not_active IP Right Cessation
- 1991-01-04 SK SK12-91A patent/SK279200B6/sk not_active IP Right Cessation
-
1992
- 1992-07-02 NO NO19922622A patent/NO310472B1/no not_active IP Right Cessation
- 1992-07-03 FI FI923099A patent/FI106241B/fi active
- 1992-11-25 HR HRP921353 patent/HRP921353A2/xx not_active Application Discontinuation
-
1994
- 1994-12-01 US US08/352,077 patent/US5550051A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NO310472B1 (no) | 2001-07-09 |
US5391491A (en) | 1995-02-21 |
YU391A (sh) | 1994-04-05 |
NO922622D0 (no) | 1992-07-02 |
DE59103696D1 (de) | 1995-01-12 |
CZ279725B6 (cs) | 1995-06-14 |
WO1991009937A1 (de) | 1991-07-11 |
FI106241B (fi) | 2000-12-29 |
EP0509008A1 (de) | 1992-10-21 |
AT393277B (de) | 1991-09-25 |
FI923099A (fi) | 1992-07-03 |
ES2067921T3 (es) | 1995-04-01 |
CS9100012A2 (en) | 1991-08-13 |
EP0509008B1 (de) | 1994-11-30 |
HUT64583A (en) | 1994-01-28 |
HRP921353A2 (en) | 1995-10-31 |
FI923099A0 (fi) | 1992-07-03 |
NO922622L (no) | 1992-07-23 |
JPH05503843A (ja) | 1993-06-24 |
RU2099419C1 (ru) | 1997-12-20 |
DK0509008T3 (da) | 1995-04-18 |
US5550051A (en) | 1996-08-27 |
CA2073168C (en) | 1999-04-27 |
ATE114713T1 (de) | 1994-12-15 |
HU212597B (en) | 1996-08-29 |
JP2633392B2 (ja) | 1997-07-23 |
CA2073168A1 (en) | 1991-07-05 |
ATA1890A (de) | 1991-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK279200B6 (sk) | Biomasa na výrobu vírus/vírus antigénu jej použiti | |
CN109068710B (zh) | 一种用于生产和使用菌丝体化的高蛋白质食物组合物的方法 | |
CN101100657B (zh) | 大规模生产病毒抗原的方法 | |
Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
KR101831284B1 (ko) | 무혈청 배지에서 부유배양 되는 Vero 세포주 및 상기 세포를 사용하여 백신용 바이러스를 제조하는 방법 | |
JP5096920B2 (ja) | ウイルス物質の製造方法 | |
US4169761A (en) | Process for the cultivation of viruses | |
US3935066A (en) | Cell lines | |
RU2082757C1 (ru) | Субстрат для культивирования флавивирусов или ареновирусов на основе культуры клеток и способ получения антигена флавивируса или ареновируса | |
CN105779373A (zh) | 一种适宜稻曲病菌产孢的核糖培养基及其应用方法 | |
US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
SU1090261A3 (ru) | Способ получени биомассы базидиомицетов | |
RU2102472C1 (ru) | Способ получения биомассы чумного микроба | |
CN105779374A (zh) | 一种适宜稻曲病菌产孢的木糖培养基及其应用方法 | |
RU2353649C2 (ru) | Способ культивирования лептоспир | |
Yu et al. | Reproduction of Strain Sof'in Forest-Spring Encephalitis in Vero Cell Line Cultured on Microcarrier under Pseudo-submerged Conditions | |
RU2121501C1 (ru) | Штамм перевиваемой культуры клеток почки кошки пк-91 для репродукции парвовирусов плотоядных | |
US3712944A (en) | Stemlon and its production | |
Shameem et al. | In Vitro Difference between an Attenuated ML-17 and its Parental Virulent JaOH0566 Strain of Japanese Encephalitis Virus | |
GB2082202A (en) | Method of increasing virus yield | |
WO2011047900A2 (en) | Novel process | |
UA56033C2 (en) | A method for producing the paste-like enthomocide biological preparation based on bacillus thuringiensis | |
JPS5951996B2 (ja) | 酵母溶解微生物用培地 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100104 |